Figure 2

Outcomes of patients with ALAL by different clinical subsets. (A,B) Kaplan–Meier curve of PFS (A) and OS (B) stratified by tumor mutation burden/person by EGIL criteria. (C,D) Kaplan–Meier curve of PFS (C) and OS (D) stratified by tumor mutation burden/person by WHO 2016 criteria. (E,F) Kaplan–Meier curve of PFS (C) and OS (D) stratified by different classification systems (green curves indicating patients included in WHO 2016 criteria and red curves indicating patients who were included by the EGIL classification but excluded by the WHO 2016 classification).